Axsome Therapeutics Inc (NASDAQ:AXSM)
| 67.52 Delayed Data As of Feb 26 |  -0.86 / -1.26%Today’s Change | 35.44 Today|||52-Week Range 109.53 | -17.12% Year-to-Date |
Latest AXSM News | Press Releases
No recent news for Axsome Therapeutics Inc.
Today’s Trading
| Previous close | 68.38 |
| Today’s open | 68.18 |
| Day’s range | 66.24 - 69.58 |
| Volume | 16,181 |
| Average volume (3 months) | 303,201 |
| Market cap | $2.6B |
Data as of 3:59pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -74.42% |
| Earnings growth (this year) | -36.39% |
| Earnings growth (next 5 years) | -49.70% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 14.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DCPHDeciphera Pharmaceut... | +1.28 | +3.01% |
| RCUSArcus Biosciences In... | +1.12 | +3.27% |
| SRNESorrento Therapeutic... | -0.43 | -4.25% |
| ---- |
Data as of 4:03pm ET, 02/26/2021
Financials
| Next reporting date | March 1, 2021 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$68.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
